MEDINOL SUES BOSTON SCIENTIFIC FOR $2 TO $4 BILLION

Rory Millson, the leading attorney representing Israeli stent manufacturer Medinol in its lawsuit against Boston Scientific, announced in his opening statement that Medinol was demanding $2 billion to $4 billion. This is the first time that Medinol has announced publicly and officially the minimum sum that it was demanding from Boston Scientific as compensation for violation of the contract between the two companies, which provided for a joint development, production and market system for stents.

Globes Online (http://www.globes.co.il/serveen/globes/docview.asp?did=928424&fid=942)